Skip to content
Screener

Roivant Sciences ROIV Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$290.61M-30.1%——-$313.7M-366%-$166.04M+40.7%-$223.36M-334%
$600K-45.4%$638K-55.2%$691K-76.3%$921K-81.0%$1.1M-77.5%
$8.72M-21.4%$77.17M-7.6%$105M+25.5%$152.9M+113%$11.1M-77.9%
-$270.5M-32.4%-$163.82M+5.1%-$196.48M+5.2%-$185.66M+30.4%-$204.38M-6.0%
$419K-89.6%$1.26M+55.5%——$7.85M+688%$4.04M+318%
$281.26M+126%——————-$1.09B-112,409%
$206.73M-0.8%——————$208.29M-67.9%
-$181.51M+3.3%——$328.19M+220%——-$187.77M+71.6%
-$170.44M+88.5%-$57.79M———-$1.45M+100.0%-$1.48B-72.3%
-$270.92M-30.0%-$165.08M+4.8%-$191.55M+8.4%-$193.51M+27.7%-$208.42M-7.5%

FAQ

How much cash does Roivant Sciences generate?
Roivant Sciences (ROIV) generated -$816.5M in operating cash flow over the trailing twelve months.
What is Roivant Sciences's free cash flow?
After $13.6M of capital expenditures, Roivant Sciences's free cash flow was -$821.1M over the trailing twelve months, up 4.4% year over year.
Where does Roivant Sciences's cash flow data come from?
Every line is extracted from Roivant Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.